Taiwan Food and Drug Administration of the Ministry of Health and Welfare (TFDA) will hold “2018 Taiwan-ASEAN Drug Regulatory Symposium” in Taipei, Taiwan from 3rd to 6th September this year. The theme of the symposium is management strategy of innovative drugs such as biologics, biosimilars and vaccines. The purpose of the conference, based on the New Southbound Policy, is to strengthen communication between Taiwan and ASEAN countries, and to help Taiwan pharmaceutical industries receive the latest drug information from ASEAN countries. A former manager of US Center for Disease Control and Prevention (US CDC) and representatives of Thailand, Malaysia, Indonesia, the Philippines, and Vietnam health authorities will attend the meeting to share with their medicine management strategies.

Following the format of the first symposium in 2017, events scheduled will include: face-to-face workshop, public seminar, and site visiting for the research and analysis laboratory of TFDA and the domestic pharmaceutical industries. TFDA and the representatives from the industry will share Taiwan’s current drug regulations and the development of biomedicine in these workshops. ASEAN representatives will explain their domestic drug regulatory policy in the public seminar.

TFDA hopes to enhance the communication between ASEAN countries and increase the opportunity for cooperation with the international community.